签订大额BD 长春高新盘中涨逾7%

Group 1 - The core point of the article is that Changchun High New Technology Industry (000661) experienced a stock price increase of over 7%, closing at 96.7 CNY per share, reflecting a rise of 5.04% [2] - Changchun High New announced that its subsidiary, Sai Zheng Medical, signed an exclusive licensing agreement for the GenSci098 injection project with Yarrow Bioscience, Inc. [2] - Under the agreement, Sai Zheng Medical is expected to receive an upfront payment of 120 million USD and milestone payments related to development, regulatory, and commercialization efforts [2] Group 2 - Sai Zheng Medical has the potential to earn up to 1.365 billion USD in milestone payments related to the exclusive license [2] - After the product launch, Sai Zheng Medical will be entitled to receive over 10% of net sales as a royalty [2]